Category: Research
FSR Announces Opening of Fellowship Grant
Program supports specialized skill development of early-career physicians and researchers interested in studying sarcoidosis CHICAGO, Dec. 17, 2020 /PRNewswire/ — The Foundation for Sarcoidosis Research (FSR) is pleased to announce the opening of a new...
FSR Announces New Small Grant Awardee
FSR’s Small Grant Program The FSR Small Grant aims to support smaller scale or pilot research projects, which can be supported either singularly by FSR or through a partnership with additional funders. The goal of this program is to provide bridge funding for...
New FSR Fellowship Awardee
FSR launched its Clinical and Research Fellowship Program in Fall 2017. We’ve invested over $1 million into this program, which aims to increase the number of specialized doctors and researchers in the sarcoidosis space. This investment in early career...
Advancing how we Diagnose and Treat Sarcoidosis
Sarcoidosis is difficult to treat for many reasons. Mainly, there is not one clear way to treat sarcoidosis because it manifests in many forms and the cause is unknown. For this reason, there are also many ways to diagnose sarcoidosis, making it a diagnosis of...
aTyr Pharma Announces Positive Interim Safety Results from Ongoing Phase 1b/2a Clinical Trial of ATYR1923
FSR has partnered with aTyr Pharma, Inc. to help inform patients about an ongoing clinical trial for ATYR1923, a potential new treatment for pulmonary sarcoidosis (ATYR1923-C-002, NCT03824392.) aTyr recently issued a press release, republished with permission below,...
Clinical Trial: Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
New clinical trial opportunity in New Haven, CT!
New Publication on Socioeconomic Factors and Sarcoidosis
There are many ways that patients can help advance sarcoidosis research and aid in finding a cure. For example, patients can host fundraisers in their hometowns, participate in clinical trials, and raise awareness about the disease. All of these efforts make a huge...
Tofacitinib for Prednisone Dependent Pulmonary Sarcoidosis Patients
The Oregon Health and Science University is leading a new clinical trial, Tofacitinib for Prednisone Dependent Pulmonary Sarcoidosis Patients. The purpose of this study is to learn more about treatment of sarcoidosis in patients who currently require corticosteroids. ...